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Abstract
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (M. tuberculosis). TB is still a major
health problem. The Bacillus Calmette-Guérin (BCG) vaccine is the only one available for TB and is known to confer
variable levels of protection. Because of this variability, a new vaccine is needed to control TB. Proteins secreted by M.
tuberculosis are known to induce protective immunity. Within the genome of M. tuberculosis, there is a family of
proteins called resuscitation promoting factor (Rpf), which plays a role in the reactivation of M. tuberculosis. RpfD is a
member of the Rpf family that has been shown to be immunogenic, making it suitable for use as a TB vaccine. The
rpfD gene of the M. tuberculosis Beijing strain from the bacterial stock of the Department of Microbiology at the
Medical Faculty of the Universitas Indonesia was amplified using polymerase chain reaction (PCR) and then inserted
into the mammalian expression vector pcDNA3.1(+). Then, the pcDNA3.1(+)-rpfD vector was transformed to
Escherichia coli DH5α. A 465-bp target fragment was obtained, and the accuracy of the cloning was confirmed using
colony PCR, restriction enzyme digestion, and sequencing. We expect that this recombinant plasmid will induce
immunity in future animal models and thus will prove itself to be a candidate for an M. tuberculosis vaccine.

Abstrak
Konstruksi vektor pcDNA 3.2 pembawa gen penyandi RpfD dari Mycobacterium tuberculosis. Tuberkulosis (TB)
adalah penyakit infeksi yang disebabkan oleh Mycobacterium tuberculosis. TB masih menjadi permasalahan kesehatan
yang besar. Vaksin BCG (Bacillus Calmette-Guerin) adalah satu-satunya vaksin yang tersedia untuk TB yang telah
dipakai dan memiliki daya proteksi yang berbeda-beda diantara negara pengguna. Protein yang disekresikan oleh M.
tuberculosis diketahui memiliki kemampuan untuk menstimulir sistem imunitas tubuh. Salah satu keluarga protein M.
tuberculosis yang diberi nama Resuscitation promoting factor (Rpf) memainkan peranan dalam re-aktivasi bakteri ini
dari kondisi latent. Resuscitation promoting factor D (RpfD) menunjukkan sifat imunogenik sehingga memiliki potensi
sebagai vaksin TB. Gen rpfD dari M. tuberculosis strain Beijing yang merupakan stock Departemen Mikrobiologi
Fakultas Kedokteran Universitas Indonesia diperbanyak menggunakan polymerase chain reaction (PCR) kemudian
disambungkan kedalam vector pcDNA3.1(+) yang dapat melakukan ekspresi protein pada sel mamalia. Selanjutnya
pcDNA3.1(+)-rpfD ditransformasikan kedalam Escherichia coli strain DH5. Fragmen DNA sepanjang 465 bp berhasil
didapatkan pada klon hasil transformasi, fragmen tersebut kemudian dikonfirmasi dengan sekuensing untuk mengetahui
ada tidaknya mutasi dan pemotongan dengan enzim restriksi untuk mengetahui kebenaran arah insersi gen rpfD pada
klon. Kami berharap plasmid rekombinan yang didapatkan pada studi ini dapat menstimulasi sistem imunitas pada
model hewan uji sehingga menjadikannya sebagai kandidat vaksin tuberkulosis.
Keywords: Tuberculosis, M. tuberculosis, Mammalian expression vector pcDNA3.1(+), Resuscitation promoting factor
D (rpfD)
problem, affecting millions of people every year. TB is
one of the top nine causes of death for a single
infectious disease. In 2016, TB caused 1.3 million
deaths, not including an additional 0.4 million deaths
among HIV-positive people [1].

Introduction
Tuberculosis (TB) is an infectious disease caused by
Mycobacterium tuberculosis (M. tuberculosis). TB has
existed for millennia and remains a major global health
149
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More than two-thirds of the global TB burden has been
reported as being in Africa and Asia, with India,
Indonesia, and China being the three countries that have
the highest number of TB cases in the world [2]. In
Indonesia, about 1,017,378 new active TB cases were
noted in 2015, including multidrug-resistant TB.
Because of the number of people infected, TB is a
burden on the national economy [3].
TB infection can be prevented by vaccination. The
current TB vaccine is an attenuated live vaccine derived
from Mycobacterium bovis Bacillus Calmette-Guerin
(BCG). BCG is known to provide protection against
meningeal and miliary TB in infants and children.
However, it provides inefficient and inconsistent
protection against adult pulmonary TB. Over the years,
numerous hypotheses have been proposed to explain the
variability in the effectiveness of BCG protection,
which can vary from 0‒80% [4-7]. In addition, BCG
can be virulent and can cause disease in immunocompromised individuals, for example, those with AIDS
[8]. Therefore, the development of safer and more
effective vaccines is needed.
Among the new vaccine platforms, genetic vectors,
including recombinant plasmid DNA vectors, have been
widely used to deliver microbial antigen-coding genes.
These vectors can strongly induce both CD4+ and CD8+
T-cell responses, which are required for an effective TB
vaccine [9]. Primarily due to their flexibility, pcDNA3
and its derivatives are among the most commonly used
commercial mammalian expression systems. Plasmid
pcDNA3 has been widely used to make vaccines [1011] and in cancer gene therapy [12-13]. Baghani et al.
(2015) designed and produced a eukaryotic expression
vector encoding M. tuberculosis using a pcDNA3.1
vector coding map [14]. Samira et al. (2016) also used a
pcDNA3.1 vector to design a DNA vaccine encoding
the tb10.4 gene from M. tuberculosis [9].

production of IFN-γ by CD4+ T-cells [20]. More recent
studies have shown that RpfA and RpfD are recognized
by CD4+ and CD8+ T-cells from healthy individuals
who have latent infections characterized by cytokine
production against these antigens [21].
In the present study, we used one of the five Rpf family
proteins encoded by M. tuberculosis: RpfD. All proteins
in the Rpf family are able to stimulate the antibody
response, stimulate T-cell proliferation, and modulate
the immune response during infection in mice [18]. The
rpfD gene is 465 bp in length and encodes a protein
containing 154 amino acids. The RpfA and RpfD
proteins have also been shown to be immunogenic in
humans, based on their production of specific cytokines
[22].
The aim of this study was to clone the rpfD gene of the
M. tuberculosis Beijing strain from Indonesian patients
into the mammalian expression vector pcDNA3.1(+).
This recombinant plasmid is expected to induce
immunity in animal models and is considered to be a
new candidate for a TB vaccine.

Materials and Methods
DNA Extraction. M. tuberculosis Beijing strain from
Indonesian patients was isolated using a PeqGOLD
Bacterial DNA Kit (PeqLab) and kindly donated from
Pusat Biomedis dan Teknologi Kesehatan Kementrian
Kesehatan Republik Indonesia.

The development of an effective vaccine against M.
tuberculosis is a top priority for reducing TB morbidity
and mortality. To produce new TB vaccines, several
strategies have been used, including the development of
DNA vaccines encoding antigens from Mycobacteria.
Most evidence suggests that the antigens secreted by M.
tuberculosis may stimulate protective immunity [15,16].

Amplification of the rpfD gene. The rpfD gene was
amplified using PCR with specific, proprietary primers
annealing to the rpfD region. The PCR reaction mixture
contained the following ingredients: 50 pmol of forward
primer and reverse primer for rpfD; 5 μL of M. tuberculosis genomic DNA; 10 mM of dNTPs; 50 mM of
MgCl2; and 1 U/μL of Phusion Hot Start II DNA Polymerase (Thermo Fisher Scientific). The final reaction
volume was 50 μL. The first cycle of the PCR reaction
was performed for 5 min at 98 °C, followed by 30 cycles
of 30 sec at 98 °C, 30 sec at 58 °C, and 1 min at 72 °C.
The final cycle was performed for 7 min at 72 °C. The
PCR product size was confirmed by gel electrophoresis
and then purified using a GeneJET PCR Purification Kit
(Thermo Fisher Scientific).

In the development of new TB vaccines, the
resuscitation promoting factor (Rpf) family of proteins
is considered a promising group of target antigens
[17,18]. M. tuberculosis encodes five Rpf proteins:
RpfA (Rv0867c), RpfB (Rv1009), RpfC (Rv1884c),
RpfD (Rv2389c), and RpfE (Rv2450c) [19]. A number
of studies have investigated the immune response to
Rpf. A mouse infection study showed that RpfA, RpfB,
RpfD, and RpfE were immunogenic [17-18]. It has also
been demonstrated that the Rpf antigen induces the

rpfD cloning into vector pcDNA3.1(+). The PCR
product and plasmid pcDNA3.1(+) were digested using
EcoRI (BioLabs) and HindIII (Thermo Fisher Scientific). These enzymes have restriction sites within
pcDNA3.1(+). The reaction was performed twice for
each enzyme with a specific buffer and condition. Then,
the digested products were purified using a GeneJET
PCR Purification Kit for the PCR fragments and a
GeneJET Plasmid Miniprep Kit (Thermo Fisher Scientific) for the pcDNA3.1(+). Ligation of digested rpfD
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into pcDNA3.1(+) vector was performed using T4 DNA
Ligase (Thermo Fisher Scientific).
Escherichia coli (E. coli) DH5α was treated with 0.05
M of cold CaCl2 solution to make bacteria ready to
accept foreign DNA. This strain was selected because it is
appropriate for cloning. Competent cells were transformed
using the heat-shock method [23]. The transformed
bacteria were cultured on lysogeny broth (LB) agar
containing ampicillin at a concentration of 100 μg/mL.
Colony PCR was performed to identify colonies
containing the recombinant vector, which was then
extracted using a GeneJET Plasmid Miniprep Kit
(Thermo Fisher Scientific). The accuracy of the cloning
was confirmed using enzyme digestion with StuI
(Thermo Fisher Scientific), followed by sequencing
(BioEdit software).

Results and Discussion
We amplified rpfD from the M. tuberculosis Beijing
strain from Indonesia patients using PCR. A 465-bp
fragment was obtained following gel electrophoresis
Kb

M
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using 1.5% agarose (Figure 1). The genetic background
of various M. tuberculosis strains may affect the induction of an immune response, drug resistance patterns,
clinical features, epidemiology, and pathogenic characteristics that determine disease progression after infection [24]. The use of the Beijing strain from Indonesian
patients was based on the results of prior studies that
suggested that most of the isolates of M. tuberculosis in
Indonesia are from the Beijing strain [25,26]. The use of
the Beijing strain in vaccine development is expected to
support the discovery of vaccine candidates that can be
produced in Indonesia.
After digestion using EcoRI and HindIII, the PCR product showed no significant change in size, and the
pcDNA3.1(+) vector demonstrated a 5387-bp fragment
(Figure 2).
In the next step, the target gene was inserted into the
backbone using T4 DNA Ligase. The ligation product
was used to transform E. coli DH5α and yielded 100
colonies. Colony PCR was performed using the forward
and reverse primers for rpfD to confirm gene insertion
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Figure 1. Amplification, Digestion, and Purification of rpfD Gene-Coding Region. kb: kilobase; Lane M: 1-kb DNA Ladder;
Lane 1: PCR Product of the rpfD Gene-coding Region; Lane 2: rpfD Gene-Coding Region Digested Using EcoRI
and HindIII; Lane 3: rpfD Gene-Coding Region After Digestion and Purification. The Black Arrow Shows A Band
that Correlates to the Length of the rpfD
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Figure 2. Digestion of the pcDNA3.1(+) Vector Using Restriction Enzymes. kb: Kilobase, Lane M: 1-kb DNA Ladder; Lane
1: pcDNA3.1(+) Digested Using EcoRI and HindIII. The Black Arrow Shows A Band that Correlates to the Length
of the Wild-Type pcDNA3.1(+) Vector
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into the pcDNA3.1(+) in 28 colonies that were chosen
randomly. The colony PCR product was gel electrophoresed, and a 465-bp fragment was observed (Figure
3), indicating that the rpfD gene was successfully inserted into the pcDNA3.1(+) plasmid.

in the development of TB vaccines. Although pcDNA3.1
vector may have a different protein character than rpfD,
some genes have successfully been cloned into it, including cfp10, ag85a, and tb10.4 [31,32], suggesting
that pcDNA3.1(+) is a suitable vector for cloning M.
tuberculosis genes.

The vector used in this study, pcDNA3.1(+), uses a cytomegalovirus (CMV) promoter to express the rpfD
gene in mammalian cell lines. This CMV promoter produces a higher transgene expression in tissues than all
other promoters and can increase the expression level of
recombinant proteins in various cell types [27,28]. In
addition, pcDNA3.1(+) contains pUCori, which facilitates replication in bacterial cells, as well as bovine growth
hormone (BGH) polyadenylation-signal and transcription-termination sequences, which function to increase
the stability of the mRNA [29,30]. These features have
made pcDNA3.1(+) plasmid a common choice for use
Kb
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Five colony PCR products were selected, purified using a
GeneJET PCR Purification Kit, and then digested using
StuI, a restriction enzyme that digests pcDNA3.1(+)
vector on base 2053. The results showed that all colonies
had a larger digest product than the pcDNA3.1(+) wildtype control (Figure 4). The accuracy of the cloning was
confirmed using sequencing (BioEdit software), the
sequencing results demonstrated that the rpfD DNA
sequence was appropriate when compared with the sequences of the M. tuberculosis H37Rv strain, and no
mutations were found in it.
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Figure 3. Colony PCR to Grow Colonies on Selective Medium After DNA Recombinant Transformation. kb: kilobase; M: 1kb DNA ladder; Lanes 1-14: Colony PCR from E. coli Transformed Using pcDNA3.1(+)-rpfD; +ve: Positive Control
Amplification of rpfD from M. tuberculosis H37Rv; -ve: Negative Control Amplification of rpfD from pcDNA3.1(+)
Wild-Type Template. The Black Arrow Shows A Band that Correlates to Length of the pcDNA3.1(+) Vector
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Figure 4. Confirmation of rpfD Insertion Into the pCDNA3.1(+) Vector Using Restriction Enzyme Digestion. kb: Kilobase;
M: 1-kb DNA Ladder; Lane 1: pcDNA3.1(+) Without Digestion; Lane 2: pcDNA3.1(+) Digested Using StuI; Lanes
37: Colonies Transformed with pcDNA3.1(+)-rpfD Digested Using StuI
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Several studies have shown that RpfD can induce a
strong cellular immune response. One recent study evaluated the efficacy of a DNA vaccine containing rpfD that
was injected into mice. It successfully induced a cellular
immune response, as indicated by IFN-γ production [17].
It has also been demonstrated other Rpf family proteins
like RpfA, RpfB, and RpfE are immunogenic in mice
and can provide protection via humoral and cellular immune responses [18]. We propose to expand this study
by expressing RpfD protein and investigating its immunogenicity in a mouse model.

Conclusions
In the present study, we successfully constructed a
pcDNA3.1(+) vector encoding rpfD from M. tuberculosis
for use as a vaccine antigen. Future studies will probe
the RpfD protein-induced production of IFN-γ IL-12
and IgG in animal models, which may lead to promising
results for human administration.
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